Product News

Share this article:

Wyeth received FDA approval for a new indication on Tygacil, a pneumonia drug. The additional indication was approved for adult patients with community-acquired bacterial pneumonia.

 

A New York federal judge has asked the FDA to make Plan B, an emergency contraceptive, available to 17-year-olds within 30 days. US District Judge Edward Korman also asked the agency to review whether to make the product available for girls of all ages, without a prescription. Plan B is manufactured by Barr Pharmaceuticals, a division of Teva Pharmaceuticals.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients